Health Condition 1: E282- Polycystic ovarian syndrome
Conditions
Interventions
Intervention1: Combined oral contraceptive pills:
1st group (Group A): Patients will receive COCP(Tab Ethinylestradiol 30mcg and Levonorgestrel 0.15mg) once daily from day 1 to day 21 of the cycle an
Sponsors
AIIMS Bhopal
Endocrine Society of India
Eligibility
Inclusion criteria
Inclusion criteria: 1)Adult females aged 18-40 years 2)Diagnosed with PCOS by the 2003 Rotterdam criteria.
Exclusion criteria
Exclusion criteria: 1) Pregnancy/ Lactation 2) Treatment with OCPs/Sex steroids or Metformin in the last 6 months 3) Contraindications for OCP use (WHO CAT-4) 4) History of Intolerance to Metformin or OCP.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum Anti-Mullerian Hormone (AMH)Timepoint: Baseline, 3 months, and 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Regularization of menstrual cycle 2.Modified Ferriman-Gallwey score for hirsutism. 3.BMI / Waist circumference.Timepoint: Baseline, 3 months and 6 months;1. HOMA-IR 2. T. Cholesterol/ S. Triglycerides/ LDL-Cholesterol & HDL-Cholesterol. 3. Serum Total testosterone& DHEAS levels 2. Serum LH : FSH Ratio Timepoint: Baseline, 3 months, and 6 months;1. Ovarian Volume Follicle No. per section (FNPS) or Follicle number per Ovary (FNPO) on either Transabdominal or Transvaginal sonographyTimepoint: Baseline, 3 months, and 6 months;1. Serum Progesterone 2. Endometrial ThicknessTimepoint: post 2 months of contraceptive pill withdrawal after 6 months of therapy in case of spontaneous onset of menstruation | — |
Countries
India
Contacts
Public ContactDr BIJIT BHARALI
ALL INDIA INSTITUTE OF MEDICAL SCIENCES, BHOPAL
Outcome results
None listed